VRDN
#1805
Viridian Therapeutics, Inc. - Common Stock
23.8 8 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.57%
Variación mensual
+22.09%
Variación en los últimos 6 meses
-16.94%
Cambio anual
+6.37%
Cierres anteriores
24.2 6
Open
23.8 8
Mínimo
23.8 8
Máximo
23.8 8
Volumen
124
Financials
- Market Capitalization 2.71 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
—
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1782 |  NRIX Nurix Therapeutics, Inc. - Common stock | 26.88 USD | +0.64% | -2.25% | +10.71% | +139.79% | 2.79 B USD | ||
| 1801 |  ATAI AtaiBeckley Inc. - Common Stock | 7.35 USD | -0.54% | -1.34% | +2.51% | +86.08% | 2.73 B USD | ||
| 1839 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 26.26 USD | -0.68% | +2.22% | +1.90% | -13.25% | 2.59 B USD | ||
| 1841 |  PGEN Precigen, Inc. - Common Stock | 7.19 USD | -3.10% | -4.13% | +29.32% | +59.07% | 2.57 B USD |